Triglyceride-to-HDL Ratio: What It Can Tell You About Metabolic Health

The triglyceride-to-HDL ratio has become popular because it is simple. Both numbers are already sitting on a routine lipid panel, and the calculation takes seconds.

Its usefulness comes from the physiology behind those numbers.

Triglycerides often rise when insulin resistance alters the way the liver handles fat and energy. HDL frequently falls in the same metabolic setting. Looking at the two together can reveal a pattern that may not be obvious from fasting glucose or LDL cholesterol alone.

How the Triglyceride-to-HDL Ratio Is Calculated

Using conventional U.S. laboratory units, divide the triglyceride level in mg/dL by the HDL cholesterol level in mg/dL.

For example, triglycerides of 120 mg/dL and HDL-C of 40 mg/dL produce a TG:HDL ratio of 3.0.

The arithmetic is easy. The interpretation requires more context.

Why Insulin Resistance Changes Triglycerides and HDL

Insulin resistance changes lipid metabolism long before many people meet the laboratory criteria for diabetes.

As insulin sensitivity declines, more fatty acids reach the liver and hepatic production of triglyceride-rich VLDL particles commonly increases. The exchange of lipids among VLDL, LDL, and HDL changes as well.

This metabolic pattern often produces higher triglycerides, lower HDL-C, and changes in LDL particle composition.

A person can therefore have a normal fasting glucose and a normal hemoglobin A1c while the lipid panel is already showing evidence of metabolic stress.

This is one reason we frequently interpret the TG:HDL ratio alongside fasting insulin and HOMA-IR.

There Is No Universal “Optimal” TG:HDL Ratio

The internet is full of precise triglyceride-to-HDL targets. The research is less tidy.

Studies consistently find that higher TG:HDL ratios are associated with insulin resistance and cardiometabolic risk, but the thresholds used to identify that risk differ by sex, ethnicity, age, and study population.

A 2024 systematic review covering 32 studies and nearly 50,000 participants found meaningful variation in the performance of the ratio across populations. The average thresholds identified across the studies were approximately 2.5 for women and 2.8 for men, but the authors specifically cautioned against assuming one cutoff applies to everyone.

For practical interpretation, we generally prefer a lower ratio to a higher one, especially when the change is accompanied by rising triglycerides, increasing visceral fat, higher fasting insulin, or deteriorating glucose regulation.

A TG:HDL ratio should not be used by itself to diagnose insulin resistance.

Triglycerides Tell Us About More Than Insulin Resistance

Triglycerides are transported through the bloodstream in lipoprotein particles, particularly chylomicrons and VLDL. As these particles are metabolized, cholesterol-rich remnant particles remain in circulation.

These remnants are ApoB-containing particles and can participate in atherosclerosis.

This is clinically important because elevated triglycerides may represent more than excess stored energy. They can also signal increased traffic through triglyceride-rich lipoprotein pathways and greater remnant particle exposure.

Our related article on remnant cholesterol explains this part of the lipid profile in more detail.

Where ApoB Fits

The TG:HDL ratio and ApoB answer different questions.

The TG:HDL ratio provides information about a metabolic pattern. ApoB estimates the number of circulating atherogenic lipoprotein particles.

In insulin resistance and hypertriglyceridemia, LDL particles may become relatively cholesterol depleted. LDL-C can therefore appear less concerning than the actual number of ApoB-containing particles would suggest.

This is one of the situations where measuring ApoB can be particularly useful.

The 2026 ACC/AHA dyslipidemia guideline specifically recognizes ApoB as useful when triglycerides are elevated, diabetes or cardiometabolic disease is present, or LDL-C may underestimate residual atherogenic particle burden.

Read ApoB vs LDL-C: What Actually Matters? for a more complete explanation.

A Low TG:HDL Ratio Does Not Cancel High ApoB

This distinction has become more important as very-low-carbohydrate and ketogenic diets have become more common.

A lean, physically active, insulin-sensitive person can have low triglycerides and a favorable TG:HDL ratio while LDL-C and ApoB are markedly elevated.

The low ratio is useful information. It suggests a different metabolic phenotype from the more familiar combination of high triglycerides, low HDL, visceral obesity, and insulin resistance.

It does not establish that a very high ApoB is harmless.

Metabolic health and atherogenic particle exposure are related parts of cardiovascular risk, but they are not interchangeable measurements.

A High Ratio Does Not Automatically Mean ApoB Is High

The reverse assumption should also be avoided.

A high TG:HDL ratio may increase suspicion for an insulin-resistant, triglyceride-rich lipid pattern, but the ratio does not count ApoB particles.

If knowing atherogenic particle burden would change the clinical decision, ApoB should be measured rather than estimated from the ratio.

The same principle applies to remnant cholesterol, lipoprotein(a), and cardiovascular imaging. Each provides information that TG:HDL cannot provide on its own.

Why HDL Should Be Interpreted Carefully

HDL-C is frequently described as “good cholesterol,” but a high HDL-C concentration should not be interpreted as protection from every other cardiovascular risk.

HDL biology is considerably more complex than its cholesterol concentration.

A person can have high HDL-C and still have elevated ApoB, Lp(a), hypertension, diabetes, or coronary plaque. Attempts to lower cardiovascular risk simply by pharmacologically raising HDL-C have also failed to produce the benefits once expected.

Within the TG:HDL ratio, HDL remains useful because low HDL commonly accompanies insulin-resistant dyslipidemia. It should not be treated as a cardiovascular antidote to high ApoB.

What Can Raise the TG:HDL Ratio?

• Insulin resistance
• Visceral fat accumulation
• Excess caloric intake
• High intake of refined carbohydrates in susceptible individuals
• Fatty liver and increased hepatic triglyceride production
• Excess alcohol intake
• Low physical activity
• Poorly controlled diabetes
• Some medications
• Genetic disorders affecting triglyceride metabolism

Persistently elevated triglycerides deserve clinical evaluation rather than being attributed automatically to one dietary factor.

Fasting Versus Nonfasting Triglycerides

Triglycerides change after eating, so the timing of the blood draw can influence the ratio.

Modern cardiovascular guidelines increasingly accept nonfasting lipid testing for routine risk assessment. There are still situations where a fasting measurement is useful, particularly when triglycerides are substantially elevated or when the clinician is trying to characterize a specific metabolic or lipid abnormality.

When following the TG:HDL ratio over time, drawing laboratories under reasonably similar conditions makes trends easier to interpret.

Body Composition Can Explain Part of the Pattern

Insulin resistance is often associated with visceral fat, but body weight alone is a poor way to estimate it.

Two people with the same BMI can have very different amounts of abdominal visceral fat and skeletal muscle.

DEXA and SECA body composition testing can provide additional information when metabolic markers are changing despite relatively stable body weight.

Muscle matters as well. Skeletal muscle is one of the major sites for glucose disposal, which is one reason preserving or increasing lean mass remains central to metabolic health as we age.

Explore our Body Composition and Longevity Medicine resources.

How We Use the Ratio at HormoneSynergy®

We do not treat the TG:HDL ratio as a diagnosis or a treatment target by itself.

When the ratio is higher than expected or has been changing over time, we look at what is happening around it.

That can include triglycerides, ApoB, non-HDL-C, remnant cholesterol, fasting insulin, glucose, hemoglobin A1c, HOMA-IR, Lp(a), blood pressure, liver health, visceral fat, body composition, exercise, alcohol intake, sleep, medications, and family history.

The same ratio can mean something different in a person with visceral obesity and rising fasting insulin than it does in someone with normal insulin sensitivity and a genetic triglyceride disorder.

For the broader clinical framework, see Metabolic Health and Insulin Resistance: A Longevity Medicine Guide.

Improving an Unfavorable TG:HDL Pattern

Treatment should be directed at the cause rather than the ratio itself.

For many patients, improving insulin sensitivity through regular exercise, resistance training, loss of excess visceral fat, adequate protein, improved dietary quality, better sleep, and limiting excess alcohol can substantially improve triglycerides.

Omega-3 fatty acids can lower triglycerides at appropriate doses, although the clinical use of omega-3 therapy depends on the formulation, dose, triglyceride level, and cardiovascular context.

Learn more in Omega-3 and Triglycerides: What the Evidence Shows.

Marked or persistent hypertriglyceridemia may require medical therapy, particularly when triglyceride levels become high enough to increase pancreatitis risk or when the broader cardiovascular profile warrants treatment.

What the TG:HDL Ratio Does Well

It is inexpensive, immediately available, and useful for recognizing a common metabolic pattern.

It can raise suspicion for insulin resistance before glucose becomes obviously abnormal. It can prompt a closer look at visceral fat, fasting insulin, remnant particles, diet, exercise, alcohol, sleep, and other drivers of metabolic health.

Its usefulness drops when it is promoted as a precise diagnostic test or as a substitute for ApoB, fasting insulin, or direct cardiovascular risk assessment.

Frequently Asked Questions

What is a good triglyceride-to-HDL ratio?

Lower ratios are generally associated with a more favorable metabolic profile, but there is no universally accepted diagnostic cutoff. Research thresholds vary by sex, ethnicity, and population. The ratio is best interpreted with other metabolic markers.

Does the TG:HDL ratio diagnose insulin resistance?

No. It is a useful surrogate marker associated with insulin resistance, but it does not directly measure insulin sensitivity. Fasting insulin, HOMA-IR, glucose regulation, body composition, and the broader clinical picture can provide additional information.

Can glucose and A1c be normal with a high TG:HDL ratio?

Yes. Compensatory increases in insulin can maintain normal glucose for years while metabolic changes are developing. This is one reason fasting insulin and lipid patterns can provide useful information earlier in the process.

Does a low TG:HDL ratio mean cardiovascular risk is low?

Not necessarily. A low ratio is generally metabolically favorable, but cardiovascular risk can still be increased by high ApoB, elevated Lp(a), hypertension, smoking, kidney disease, family history, or existing atherosclerosis.

Can someone have low triglycerides and very high ApoB?

Yes. Triglycerides and ApoB measure different aspects of lipid metabolism. Some metabolically healthy individuals have low triglycerides while LDL-C and ApoB remain markedly elevated.

Should ApoB be measured if the TG:HDL ratio is high?

ApoB can be especially useful when triglycerides are elevated, insulin resistance is present, or LDL-C may not accurately reflect atherogenic particle burden. Whether it is necessary depends on the individual cardiovascular risk assessment.

How can the TG:HDL ratio be improved?

The most effective approach is to identify what is driving the pattern. Exercise, resistance training, reduction of excess visceral fat, improved insulin sensitivity, dietary changes, limiting excess alcohol, better sleep, and treatment of underlying metabolic disease can all affect triglycerides and HDL.

References

• Scicali R, et al. The Triglyceride/HDL Ratio as a Surrogate Biomarker for Insulin Resistance. Biomedicines. 2024;12(7):1493. PMID: 39062066.
• Salazar MR, et al. Relation among the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio, insulin resistance, and associated cardiometabolic risk factors in men and women. American Journal of Cardiology. 2012;109(12):1749-1753.
• Blumenthal RS, Morris PB, et al. 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia. Circulation. 2026.
• Li B, et al. Remnant cholesterol is more positively related to diabetes, prediabetes, and insulin resistance than conventional lipid parameters and lipid ratios. Journal of Diabetes. 2024;16(8):e13592.

Editorial Transparency

This article is an independent HormoneSynergy® review of current metabolic and cardiovascular research. It is educational and does not replace individualized medical evaluation. Laboratory values should be interpreted in the context of medical history, medications, body composition, blood pressure, family history, lifestyle, and other relevant cardiovascular and metabolic findings.